| Incidence of hepatocellular carcinoma in patients with HCV-associated cirrhosis treated with direct-acting antiviral agents V Calvaruso, G Cabibbo, I Cacciola, S Petta, S Madonia, A Bellia, F Tinè, ... Gastroenterology 155 (2), 411-421. e4, 2018 | 332 | 2018 |
| Direct-acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients G Cabibbo, C Celsa, V Calvaruso, S Petta, I Cacciola, MR Cannavò, ... Journal of hepatology 71 (2), 265-273, 2019 | 169* | 2019 |
| Childhood IQ measurements in infants with transient congenital hypothyroidism F Calaciura, G Mendorla, M Distefano, S Castorina, T Fario, RM Motta, ... Clinical endocrinology 43 (4), 473-477, 1995 | 152 | 1995 |
| Is early recurrence of hepatocellular carcinoma in HCV cirrhotic patients affected by treatment with direct‐acting antivirals? A prospective multicentre study G Cabibbo, S Petta, V Calvaruso, I Cacciola, MR Cannavò, S Madonia, ... Alimentary pharmacology & therapeutics 46 (7), 688-695, 2017 | 136 | 2017 |
| Rete Sicilia Selezione Terapia–HCV (RESIST-HCV). Incidence of hepatocellular carcinoma in patients with HCV-associated cirrhosis treated with direct-acting antiviral agents V Calvaruso, G Cabibbo, I Cacciola, S Petta, S Madonia, A Bellia, F Tinè, ... Gastroenterology 155 (2), 411-421, 2018 | 69 | 2018 |
| Real-world experience with obeticholic acid in patients with primary biliary cholangitis D D’Amato, A De Vincentis, F Malinverno, M Viganò, D Alvaro, M Pompili, ... JHEP Reports 3 (2), 100248, 2021 | 56 | 2021 |
| Is transient elastography needed for noninvasive assessment of high-risk varices? The REAL experience V Calvaruso, I Cacciola, A Licata, S Madonia, R Benigno, S Petta, ... Official journal of the American College of Gastroenterology| ACG 114 (8 …, 2019 | 50 | 2019 |
| Rete Sicilia Selezione Terapia-HCV (RESIST-HCV). Is early recurrence of hepatocellular carcinoma in HCV cirrhotic patients affected by treatment with direct-acting antivirals … G Cabibbo, S Petta, V Calvaruso, I Cacciola, MR Cannavò, S Madonia, ... Aliment Pharmacol Ther 46 (7), 688-695, 2017 | 32 | 2017 |
| Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a … S Petta, M Marzioni, P Russo, A Aghemo, A Alberti, A Ascione, A Antinori, ... The Lancet Gastroenterology & Hepatology 2 (6), 427-434, 2017 | 24 | 2017 |
| Visual and hearing impairment are associated with delirium in hospitalized patients: results of a multisite prevalence study A Morandi, M Inzitari, C Udina, N Gual, M Mota, E Tassistro, A Andreano, ... Journal of the American Medical Directors Association 22 (6), 1162-1167. e3, 2021 | 19 | 2021 |
| Liver injury, SARS‐COV‐2 infection and COVID‐19: What physicians should really know? A Licata, MG Minissale, M Distefano, G Montalto GastroHep 3 (3), 121-130, 2021 | 16 | 2021 |
| Disease outcomes after DAA-induced SVR: data from the resist-HCV cohort V Calvaruso, S Petta, I Cacciola, G Cabibbo, F Cartabellotta, A Di Rosolini, ... Digestive and Liver Disease 50 (1), 1-2, 2018 | 16 | 2018 |
| Liver and cardiovascular mortality after hepatitis C virus eradication by DAA: Data from RESIST‐HCV cohort V Calvaruso, S Petta, I Cacciola, G Cabibbo, F Cartabellotta, M Distefano, ... Journal of Viral Hepatitis 28 (8), 1190-1199, 2021 | 15 | 2021 |
| High efficacy and safety of flat-dose ribavirin plus sofosbuvir/daclatasvir in genotype 3 cirrhotic patients A Pellicelli, V Messina, V Giannelli, M Distefano, VP Palitti, P Vignally, ... Gut and Liver 14 (3), 357, 2020 | 12 | 2020 |
| Predictors of serious adverse events and non‐response in cirrhotic patients with primary biliary cholangitis treated with obeticholic acid A De Vincentis, D D'Amato, L Cristoferi, A Gerussi, F Malinverno, A Lleo, ... Liver International 42 (11), 2453-2465, 2022 | 11 | 2022 |
| C003 Early occurrence of hepatocellular carcinoma (HCC) in patients with HCV cirrhosis treated with direct-acting antivirals (DAAs) GGMD V. Calvaruso EASL HCC Summit 2017 1, 114-115, 2017 | 11 | 2017 |
| Molecular mechanism of the increased glucose transport in transformed FRTL-5 rat thyroid cells. FS Foti D, Damante G, Russo D, Distefano M, Grasso G, Fusco A Biochem Biophys Res Commun 191 (1), 289-294, 1993 | 9 | 1993 |
| Occurrence of hepatocellular carcinoma in patients with hepatitis C virus related liver disease treated with direct-acting antivirals V Calvaruso, G Cabibbo, I Cacciola, S Petta, S Madonia, A Bellia, ... Journal of Hepatology 1 (66), S23-S24, 2017 | 8 | 2017 |
| The HCV Sicily Network: a web-based model for the management of HCV chronic liver diseases F Cartabellotta, V Di Marco Eur Rev Med Pharmacol Sci 20 (1 Suppl), 11-16, 2016 | 8 | 2016 |
| Ustekinumab is a promising option for the treatment of postoperative recurrence of Crohn's disease FS Macaluso, M Grova, F Mocciaro, R Di Mitri, AC Privitera, ME Distefano, ... Journal of Gastroenterology and Hepatology 38 (9), 1503-1509, 2023 | 7 | 2023 |
